News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Hullin Hu

Articles by Hullin Hu

12 TIP HARMONIA SOLTI-2101/ AFT-58: A Head-to-Head Phase III Study Comparing Ribociclib (RIB) and Palbociclib (PAL) in Patients (pts) With Hormone Receptor– Positive/HER2-Negative/HER2- Enriched (HR+/HER2−/HER2-E) Advanced Breast Cancer (ABC)

ByLisa A. Carey, MD,Tomas Pascual,Daniel Stover,Astrid Thuerigen,Charles Perou,Eva Ciruelos,Ana Casas,Patty Spears,Estelle Roux,Faye Su,Hullin Hu,Yen-Shen Lu,Sara M. Tolaney, MD, MPH,Ann H. Partridge, MD, MPH,Guillermo Villacampa,Juan Manuel Ferrero-Cafiero,Aleix Prat

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

Poorer Outcomes Observed for Black Patients Undergoing Chemotherapy for AML

All-Oral Revumenib Regimen May Show Advantage in Newly Diagnosed AML

Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma

Blinatumomab/Ponatinib Provides Chemo-Free Option in Ph+ ALL

Early Efficacy Highlighted With Odronextamab/CHOP in Untreated DLBCL

© 2025 MJH Life Sciences^®

All rights reserved.